Perspective Therapeutics Inc (CATX)

[Bigtrade PT]

IsoRay, Inc. Analyst Rating Update - by Bill Horton on June 9, 2015

IsoRay, Inc. (NYSEMKT:ISR): The Company shares has received a rating of Buy from 1 Wall Street Analysts. IsoRay, Inc. shares have received a Mean Price Target of $5. According to the rating issued from 1 Wall Street Analysts, the High Price Target is seen at $5 while the Lower end of the Price Target is seen at $5. The Median Price Target is calculated at $5.

IsoRay, Inc. (NYSEMKT:ISR) witnessed a decline in the market cap on Monday as its shares dropped 2.52% or 0.04 points. After the session commenced at $1.57, the stock reached the higher end at $1.65 while it hit a low of $1.54. With the volume soaring to 1,479,816 shares, the last trade was called at $1.55. The company has a 52-week high of $3.79. The company has a market cap of $85 million and there are 54,907,000 shares in outstanding. The 52-week low of the share price is $1.22. According to the SEC Form-4 filing, the Company has disclosed other insider buying and selling activities, The officer (Vice President), of Isoray, Inc., Cavanagh William had unloaded 13,340 shares at $1.53 per share in a transaction on April 2, 2015. The total value of transaction was $20,410. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

http://www.insidertradingreport.org/isoray-inc-analyst-rating-update/66027/